Method
In this descriptive study conducted from February to August 2013, we tested consecutive urine specimens for the presence of antibiotics with a modified urine antibacterial substance assay (UABA) and compared the results obtained with the accuracy of antibiotic data entry on the accompanying request forms. In addition, the consequences of culturing urine specimens with incomplete antibiotic history received in the laboratory were investigated. 
Results

Out
Conclusion
This internal audit demonstrates how the accurate history of current antibiotic usage in the request forms impacts the interpretation of urine culture results.
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1. What is known about this subject? Easy availability of over the counter antibiotics in India often results in unreported antibiotic use. Antibiotics, when used for urinary tract infections, become an important confounding factor in the correct interpretation of urine culture results.
What new information is offered in this study?
We found that more than one-third of the urine specimens had antibiotic activity, while documented history of antibiotic usage was available for only 2.84 per cent of the samples.
What are the implications for policy, research or practice?
This internal audit practice demonstrates the importance of current history of antibiotic usage in the correct interpretation of urine culture results.
Background
Urinary tract infections (UTIs) are usually diagnosed on the basis of history, physical examination, urinalysis and urine 
Method
Detection of antibacterial activity in the urine We followed the modified urine antibacterial substance assay (UABA) described by Wilson et al., 2 a technique which was originally described by Sombrero et al. 3 and others 4,5 by using two Mueller-Hinton agar plates each inoculated with a lawn of Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 25923. The ATCC strains were suspended in 0.85 per cent sterile saline and adjusted to a 0.5 McFarland standard using a nephelometer. A sterile cotton swab was dipped into the standardised suspension and excess fluid removed by rotation of the swab against the side of the tube. The plates were then inoculated by streaking the swab all over the surface of the medium (lawn culture) three times, by rotating the plate through an angle of 60° after each application as is done for the modified Kirby-Bauer method. 6 Autoclaved sterile discs of 6mm diameter were prepared from Whatman Grade 1 filter paper (Whatman International, Ltd., Maidstone, England). After the inoculum dried, the discs were placed aseptically on the inoculated plates at a distance of 10-12mm apart. One loopful of urine (1µl) was transferred from each urine specimen on to the correspondingly labelled autoclaved disc aseptically.
Quality control (QC) was ensured by placing one set as a negative control, i.e., discs without antibiotics. For S. aureus ATCC 25923, another set was inoculated with a panel of gram positive standard antibiotic impregnated discs comprising penicillin (10 units), ampicillin (10µg), gentamicin (10µg), norfloxacin (10µg), cefotaxime (30µg) and vancomycin (30µg). Similarly, a panel of gram-negative antibiotic discs comprising nitrofurantoin (300µg), nalidixic acid (30µg), norfloxacin (10µg), cefotaxime (30µg), gentamicin (10µg), and imipenem (10µg) were used for testing E. coli ATCC 25922. QC was passed when the negative control showed no zone of inhibition around the disc and the positive control showed a zone of inhibition of appropriate size around the disc as per CLSI guidelines. 7 
Urine cultures
All urine specimens received in the laboratory from 1 February 2013 to 31 August 2013 were processed using standard methods for processing urine specimens, 1 
Modified Urine Antibacterial Substance Assay (UABA)
Simultaneously each urine sample was inoculated onto an individual disc on each Mueller-Hinton plate (one with Escherichia coli ATCC 25922 and the other Staphylococcus aureus ATCC 25923) using a 1μL loop. Each disc on both plates was labelled with the corresponding urine sample number and incubated overnight at 35-37°C along with the routine culture plates. Any zone of inhibition around the disc was considered positive for antibacterial activity. Figure  1 shows the modified UABA (Urine Antibacterial substance Assay) using E.coli ATCC 25922 and S.aureus ATCC 25923. Statistical analyses included descriptive statistics like percentages and proportions. All statistical analyses were performed using SPSS software (version 16.0, SPSS, Chicago, USA).
Results
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The results of the urine culture and UABA are depicted in Table 1 . Comparison of antibiotic screening of urine with antibiotic data entry from request forms was done. True-positive was defined as those urine specimens that were UABA positive and antibiotic history (AH) from request forms was available. True-negative was defined as those urine specimens that were UABA negative and antibiotic history was not specified. False-positive was defined as those urine specimens that were UABA positive but antibiotic history was negative. Lastly, false-negative were those urine specimens that were UABA negative but had antibiotic history.
The data obtained from the 2,040 urine samples as depicted in the Compliance in obtaining antibiotic histories for inpatients (37; 97.37 per cent) was higher than that reported for outpatients (1; 2.63 per cent).
Discussion
The true-positive UABA results correlated well with transcribed history provided on the laboratory request forms and the false-negatives could indicate inert drug compounds, counterfeit anti-infective drugs, and/or the patient's ignorance of the content of medicine consumed.
2
The false-negative UABA could also indicate the empiric antibiotic to be used by the physician in the treatment of the suspected UTI. In our study, 60.1 per cent of positive UABAs showed no growth, re-emphasising the fact from earlier studies 2, [8] [9] [10] that samples sent to the microbiology laboratory during a course of antibiotic treatment may not yield clinically significant results.
In this study, a total of 683 (33.48 per cent) false-positive results were detected by UABA test. The high numbers of false-positive results indicate the use of antibiotics prior to culture and/or other antibacterial substances present in the urine. This could be due to: (1) the history was not taken properly; (2) the patient either could not or was unwilling to give history due to ignorance of content of medicine, 3 poor recall, or intentional false denial due to self-perceived misuse of drugs; or (3) the antibiotic treatment of a patient with infection other than urinary tract infection. Beers et al. found that medication histories were frequently inaccurate due to failure to obtain or document the antibiotic taken or patient denial of usage. 11 Inaccurate interpretation of culture reports and promoting the emergence of drug resistance can result from this practice. 12 Leading questions regarding drug history by using the brand names of antibiotics can reduce the recall errors. 3 The absence of pyuria provides strong evidence against the presence of urinary tract infection. 10, 12 However, sterile Obtaining recent antibiotic history from a patient and including it in the request forms is often neglected, and this diagnostic information can influence interpretation of culture results. Limited sensitivity of urine cultures due to prior antibiotic consumption enforces the need to take proper history and avoid sending such samples for culture to the microbiology lab. Such periodic laboratory audits could significantly improve patient care, limit misuse of antibiotics, and have a lasting impact on the quality of the laboratory report.
Conclusion
A periodic internal audit using the UABA described here to measure the presence of antibiotics in urine cultures can prove to be a useful quality assurance tool to determine the impact on urine culture interpretation. This could raise awareness regarding the importance of obtaining antibiotic history using an evidence-based protocol. An internal quality improvement program can include UABA monitoring on a continuous basis, which might trigger a change in physicians' practices and may lead to overall quality improvement in the management of urinary tract infections.
